These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Cholecystokinin antagonists (part 1): Antinociceptive, anxiolytic and antidepressant effects of N-(5-methyl-3-oxo-1,2-diphenyl-2,3-dihydro-1H-pyrazol-4-yl)-N'-phenylureas and carboxamides.
    Author: Lattmann E, Sattayasai J, Boonprakob Y, Singh H, Lattmann P, Dunn S.
    Journal: Drug Discov Ther; 2008 Jun; 2(3):156-67. PubMed ID: 22504568.
    Abstract:
    The SAR optimization of the pyrazoline template resulted in novel 3-oxo-1,2-diphenyl-2,3-dihydro-1H-pyrazol-4-yl)-indole carboxamides and novel 3-oxo-1,2-diphenyl-2,3-dihydro-1H-pyrazol-4-yl)-N'-phenylureas. These non-peptidal heterocyclic compounds have shown to bind as potent CCK1 selective and mixed CCK antagonists in a [(125)I]CCK-8 receptor binding assay. The best amides 3c and 3d of this series displayed an IC(50) of 20 and 25 nM for the CCK(1) receptor, respectively. The best ureidopyrazoline 4b and 4e of this series displayed an IC(50) of 20 and 25 nM, as a mixed CCK receptor antagonist. In the elevated x-maze an anxiolytic effect of the urea 4e was found from 10 μg/kg upwards for the mixed antagonist. In the despair swimming test, a model for testing antidepressants, both mixed and CCK(1) selective antagonists were found active as a modulator over a big range from from 10-500 μg/kg and the magnitude of the effects were comparable to desimipramine. The amides and the phenylureas enhanced significantly the analgesic effect of morphine over a wide dose range in mice.
    [Abstract] [Full Text] [Related] [New Search]